A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline FindingsNyaradzo Mgodi, Simbarashe Takuva, Srilatha Edupuganti et al.|JAIDS Journal of Acquired Immune Deficiency Syndromes|2021Cited by 45